“The work of CASMI is timely and of vital importance. The current social contract for medical innovation is based is no longer delivering the progress that we need. Patients and participants want more, the incentives to innovate seem inadequate for the challenge and the prospects of a sustainable future for essential health care grow more complex and daunting.”
Jonathan is Professor of Health Care Law at University College London, Chair of the Health Research Authority (which protects and promotes the interests of participants, patients and the public in health research and aims to streamline its regulation) and also of the Nuffield Council on Bioethics (the nearest the UK has to a national bioethics committee). He is a member of the panel of advisers to the Morecambe Bay Investigation, due to report in late 2014.
His previous national chair roles include the Advisory Committee on Clinical Excellence Awards (2005-14) and the Human Genetics Commission (2009-12). He served on local NHS boards in Hampshire and the Isle of Wight for over twenty years up to March 2013. His roles included chairing the cluster of primary care trusts that commissioned services for the residents of Southampton, Hampshire, the Isle of Wight, and Portsmouth. He had previously chaired a strategic health authority and two provider trusts.
He chaired the UK Clinical Research Collaboration Working Party on a Strategy for Brain Tissue Banking, and sits on the Scientific Steering Committee of Brain Banks UK. He is a member of the Committee on the Ethical Aspects of Pandemic Influenza. He sat on the Organ Donation Taskforce for its work on presumed consent and has been a member of the Medical Ethics Committee of the British Medical Association. He has been involved in the preparation of ethical guidance in a number of areas of health practice.